ENANTA PHARMACEUTICALS, INC. ENTA Income Statement

Enanta pharmaceuticals, inc. (ENTA)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Jun'12	Mar'12
Royalty revenue
175,869	187,881	205,197	221,089	233,984	238,402	206,625	215,347	165,596	130,506	102,814	39,728	46,195	50,240	88,268	89,843	87,464	131,827	160,880	149,101	179,553	124,346	47,741	46,453	6,051	5,087	32,053	33,246	68,162	0	0	0
Operating expenses:
Research and development
138,568	140,113	142,213	130,417	124,443	111,772	94,856	84,447	71,367	62,887	57,451	52,437	47,815	43,954	40,461	36,010	31,478	27,703	23,189	21,342	19,642	18,996	18,740	17,838	17,324	16,306	16,841	17,466	16,690	0	0	0
General and administrative
26,119	26,015	26,246	25,913	25,897	24,823	23,441	22,729	21,827	21,582	20,749	20,071	19,120	18,085	16,966	16,219	15,580	14,592	13,543	12,611	11,571	10,698	10,016	9,005	8,190	7,118	6,183	5,578	4,997	0	0	0
Total operating expenses
164,687	166,128	168,459	156,330	150,340	136,595	118,297	107,176	93,194	84,469	78,200	72,508	66,935	62,039	57,427	52,229	47,058	42,295	36,732	33,953	31,213	29,694	28,756	26,843	25,514	23,424	23,024	23,044	21,687	0	0	0
Income (loss) from operations
11,182	21,753	36,738	64,759	83,644	101,807	88,328	108,171	72,402	46,037	24,614	-32,780	-20,740	-11,799	30,841	37,614	40,406	89,532	124,148	115,148	148,340	94,652	18,985	19,610	-19,463	-18,337	9,029	10,202	46,475	0	0	0
Other income (expense):
Interest income (expense), net
0	0	-	-	0	0	-	-	-	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	1,928	-	1,546	1,376	1,197	968	798	600	485	467	431	389	322	248	194	145	0	0	0
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	45	-	36	27	18	8	10	13	15	18	22	24	29	31	0	0	0	-	-
Change in fair value of warrant liability and Series 1 nonconvertible preferred stock
-	-	-	-	-	-	-	-	-	-105	-159	-60	-59	31	29	247	248	156	347	246	196	27	-166	-104	-56	344	381	196	214	0	0	0
Total other income (expense), net
8,715	9,010	8,819	7,974	6,897	5,718	4,793	0	0	0	-	-	-	1,914	1,719	1,757	1,597	1,335	1,307	1,034	783	497	283	305	309	637	598	367	343	0	0	0
Income (loss) before income taxes
19,897	30,763	45,557	72,733	90,541	107,525	93,121	112,195	75,688	48,806	26,947	-30,636	-18,749	-9,885	32,560	39,371	42,003	90,867	125,455	116,182	149,123	95,149	19,268	20,220	0	0	-	0	-	-	-	-
Income tax (expense) benefit
-3,768	-3,052	-826	8,121	12,677	21,251	21,165	31,151	23,358	14,423	9,237	-10,036	-5,499	-382	10,894	10,091	9,229	27,695	46,463	48,044	33,350	13,332	-15,170	0	0	0	-	-	-	-	-	-
Net income (loss)
23,665	33,815	46,383	64,612	77,864	86,274	71,956	81,044	52,330	34,383	17,710	-20,600	-13,250	-9,503	21,666	29,280	32,774	63,172	78,992	68,138	115,773	81,817	34,438	35,037	-19,154	-17,700	9,627	10,569	46,818	0	0	0
Accretion of redeemable convertible preferred stock to redemption value
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,526	3,856	5,187	0	0	0
Net income attributable to participating securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	13,670	46,959	0	0	-	0
Net income (loss) attributable to common stockholders
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-6,569	-12,094	-5,328	0	0	0
Net income (loss) per share:
Basic
-0.30	0.68	0.46	0.36	0.21	1.34	1.43	1.05	0.65	0.61	1.91	-0.44	-0.28	-0.26	-0.10	-0.06	-0.09	1.39	0.30	0.13	1.54	2.26	-0.24	2.70	-0.28	-0.30	0.23	-0.23	-2.28	1.61	-4.31	2.41
Diluted
-0.30	0.65	0.43	0.33	0.20	1.25	1.31	0.97	0.61	0.59	1.89	-0.44	-0.28	-0.26	-0.08	-0.06	-0.09	1.36	0.29	0.13	1.49	2.18	-0.23	2.61	-0.28	-0.30	0.39	-0.23	-2.28	1.45	-4.31	2.17
Weighted average shares outstanding:
Basic
19,922	19,751	19,688	19,673	19,549	19,426	19,381	19,303	19,206	19,130	19,098	19,081	19,047	19,038	19,036	18,983	18,921	18,776	18,711	18,697	18,679	18,603	-54,758	18,528	18,353	17,949	17,981	17,819	2,192	1,158	1,120	1,088
Diluted
19,922	20,773	20,873	21,105	21,084	20,810	21,064	21,017	20,601	19,918	20,462	19,081	19,047	19,038	19,723	18,983	18,921	19,269	19,350	19,277	19,268	19,283	-55,429	19,203	18,353	17,949	16,502	17,819	2,192	2,637	1,120	2,536
Royalties [Member]
Total revenue
-	-	-	221,089	-	-	191,625	0	85,596	50,506	37,814	39,728	46,195	50,240	57,692	59,185	56,597	50,554	34,077	0	0	0	-	-	-	-	-	-	-	-	-	-
Milestone [Member]
Total revenue
-	-	-	-	-	-	15,000	0	0	0	-	-	-	-	30,000	30,000	30,000	80,000	125,000	0	0	0	-	-	-	-	-	-	-	-	-	-
Other [Member]
Total revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	576	658	867	1,273	1,803	0	0	0	-	-	-	-	-	-	-	-	-	-